{"entity":{"type":"insider","cik":"0001318886","url":"/insider/0001318886","json_url":"/insider/0001318886.json","name":"Rowinsky Eric K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":15,"first":"2011-08-23","last":"2024-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Rowinsky Eric K","source":"filing","n_filings":15,"first_seen":"2011-08-23","last_seen":"2024-02-20"}],"transactions":[{"id":3155413,"accession":"0001127602-24-005922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-005922","line_url":"/filing/0001127602-24-005922#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":455.0,"shares_display":"455","price_per_share":222.54,"price_display":"222.54","price_state":"stated","total_value":101255.7,"total_display":"101,255.70","total_whole":"101,256","shares_owned_after":20629.0,"shares_owned_after_display":"20,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":8472673,"accession":"0001104659-23-021625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-021625","line_url":"/filing/0001104659-23-021625#line-1","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK, PAR VALUE $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11976.0,"shares_display":"11,976","price_per_share":0.835,"price_display":"0.84","price_state":"stated","total_value":9999.96,"total_display":"9,999.96","total_whole":"10,000","shares_owned_after":931976.0,"shares_owned_after_display":"931,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":5536044,"accession":"0001104659-21-048831","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-21-048831","line_url":"/filing/0001104659-21-048831#line-6","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":44500.0,"total_display":"44,500.00","total_whole":"44,500","shares_owned_after":720000.0,"shares_owned_after_display":"720,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-04-09","scope":"insider"},{"id":5536041,"accession":"0001104659-21-048831","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-21-048831","line_url":"/filing/0001104659-21-048831#line-5","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":4.31,"price_display":"4.31","price_state":"stated","total_value":34480.0,"total_display":"34,480.00","total_whole":"34,480","shares_owned_after":730000.0,"shares_owned_after_display":"730,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-04-09","scope":"insider"},{"id":5536038,"accession":"0001104659-21-048831","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-048831","line_url":"/filing/0001104659-21-048831#line-4","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":25200.0,"total_display":"25,200.00","total_whole":"25,200","shares_owned_after":738000.0,"shares_owned_after_display":"738,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-04-09","scope":"insider"},{"id":5536035,"accession":"0001104659-21-048831","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-048831","line_url":"/filing/0001104659-21-048831#line-3","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":7720.0,"total_display":"7,720.00","total_whole":"7,720","shares_owned_after":744000.0,"shares_owned_after_display":"744,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-04-09","scope":"insider"},{"id":5536028,"accession":"0001104659-21-048831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-048831","line_url":"/filing/0001104659-21-048831#line-2","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Fortress Biotech, Inc.","issuer_ticker":"FBIO","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":15200.0,"total_display":"15,200.00","total_whole":"15,200","shares_owned_after":746000.0,"shares_owned_after_display":"746,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-04-09","scope":"insider"},{"id":2962476,"accession":"0001104659-24-006241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-006241","line_url":"/filing/0001104659-24-006241#line-1","is_derivative":false,"issuer_cik":"0001318886","issuer_name":"Verastem, Inc.","issuer_ticker":"VSTM","issuer_name_source":null,"issuer_url":"/issuer/0001318886","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.84,"price_display":"3.84","price_state":"stated","total_value":7680.0,"total_display":"7,680.00","total_whole":"7,680","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2024-01-24","scope":"insider"},{"id":8838814,"accession":"0001104659-15-031150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-031150","line_url":"/filing/0001104659-15-031150#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10824.0,"shares_display":"10,824","price_per_share":15.77,"price_display":"15.77","price_state":"stated","total_value":170694.48,"total_display":"170,694.48","total_whole":"170,694","shares_owned_after":143688.0,"shares_owned_after_display":"143,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-27","filed_date":"2015-04-28","scope":"insider"},{"id":8443519,"accession":"0001127602-15-012316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-012316","line_url":"/filing/0001127602-15-012316#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11667.0,"shares_display":"11,667","price_per_share":475.0,"price_display":"475.00","price_state":"stated","total_value":5541825.0,"total_display":"5,541,825.00","total_whole":"5,541,825","shares_owned_after":11310.0,"shares_owned_after_display":"11,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-23","scope":"insider"},{"id":8562493,"accession":"0001127602-15-012208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-012208","line_url":"/filing/0001127602-15-012208#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2333.0,"shares_display":"2,333","price_per_share":436.137,"price_display":"436.14","price_state":"stated","total_value":1017507.621,"total_display":"1,017,507.62","total_whole":"1,017,508","shares_owned_after":11310.0,"shares_owned_after_display":"11,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":8443505,"accession":"0001127602-15-011911","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-011911","line_url":"/filing/0001127602-15-011911#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4667.0,"shares_display":"4,667","price_per_share":425.453,"price_display":"425.45","price_state":"stated","total_value":1985589.151,"total_display":"1,985,589.15","total_whole":"1,985,589","shares_owned_after":11310.0,"shares_owned_after_display":"11,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-18","scope":"insider"},{"id":8520826,"accession":"0001127602-15-011049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-011049","line_url":"/filing/0001127602-15-011049#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4666.0,"shares_display":"4,666","price_per_share":417.23,"price_display":"417.23","price_state":"stated","total_value":1946795.18,"total_display":"1,946,795.18","total_whole":"1,946,795","shares_owned_after":11310.0,"shares_owned_after_display":"11,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-11","scope":"insider"},{"id":8440782,"accession":"0001104659-15-012681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-012681","line_url":"/filing/0001104659-15-012681#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1640.0,"shares_display":"1,640","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":22943.6,"total_display":"22,943.60","total_whole":"22,944","shares_owned_after":130133.0,"shares_owned_after_display":"130,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-20","scope":"insider"},{"id":6600174,"accession":"0001104659-14-031389","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-031389","line_url":"/filing/0001104659-14-031389","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11179.0,"shares_display":"11,179","price_per_share":15.028516861973342,"price_display":"15.03","price_state":"stated","total_value":168003.79,"total_display":"168,003.79","total_whole":"168,004","shares_owned_after":132073.0,"shares_owned_after_display":"132,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-25","filed_date":"2014-04-28","scope":"insider","n_lines":2},{"id":6518939,"accession":"0001127602-14-002534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-002534","line_url":"/filing/0001127602-14-002534#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2020.0,"shares_display":"2,020","price_per_share":310.09,"price_display":"310.09","price_state":"stated","total_value":626381.8,"total_display":"626,381.80","total_whole":"626,382","shares_owned_after":10440.0,"shares_owned_after_display":"10,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-22","scope":"insider"},{"id":5149335,"accession":"0001104659-13-087579","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-087579","line_url":"/filing/0001104659-13-087579#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13903.0,"shares_display":"13,903","price_per_share":20.56,"price_display":"20.56","price_state":"stated","total_value":285845.68,"total_display":"285,845.68","total_whole":"285,846","shares_owned_after":128966.0,"shares_owned_after_display":"128,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-25","filed_date":"2013-11-27","scope":"insider"},{"id":3464230,"accession":"0001127602-12-001330","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-12-001330","line_url":"/filing/0001127602-12-001330","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12992.0,"shares_display":"12,992","price_per_share":116.0,"price_display":"116.00","price_state":"stated","total_value":1507072.0,"total_display":"1,507,072.00","total_whole":"1,507,072","shares_owned_after":9135.0,"shares_owned_after_display":"9,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-06","filed_date":"2012-01-09","scope":"insider","n_lines":2},{"id":8989222,"accession":"0001225208-11-020386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-11-020386","line_url":"/filing/0001225208-11-020386#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NEOPROBE CORP","issuer_ticker":"NEOP","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001318886","owner_name":"Rowinsky Eric K","owner_display_name":"Rowinsky Eric K","owner_url":"/insider/0001318886","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":38250.0,"total_display":"38,250.00","total_whole":"38,250","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-19","filed_date":"2011-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN INC.","url":"/issuer/0000875045","role":"Director","n_filings":7,"first_seen":"2012-01-09","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001526119","name":"Verastem, Inc.","url":"/issuer/0001526119","role":"Director","n_filings":1,"first_seen":"2024-01-24","last_seen":"2024-01-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001429260","name":"Fortress Biotech, Inc.","url":"/issuer/0001429260","role":"Director","n_filings":2,"first_seen":"2021-04-09","last_seen":"2023-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2013-11-27","last_seen":"2015-04-28"},{"type":"issuer","type_label":"ISSUER","cik":"0000810509","name":"NEOPROBE CORP","url":"/issuer/0000810509","role":"Director","n_filings":1,"first_seen":"2011-08-23","last_seen":"2011-08-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001318886","retrieved_at":"2026-08-27T02:58:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}